{
    "domain": "alchemer.eu",
    "owner": {},
    "source": [
        "DuckDuckGo-US"
    ],
    "prevalence": 0.0000141,
    "sites": 2,
    "subdomains": [
        "survey"
    ],
    "cnames": [],
    "fingerprinting": 0,
    "resources": [
        {
            "rule": "alchemer\\.eu\\/s3\\/90344126\\/CTA-Poll-17-Cost-of-decentralized-virtual-clinical-trials-vs-traditional-trials",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350250\\/Pharma-Poll-44-Regulatory-barrier-towards-adopting-software-enabled-practices",
            "cookies": 0.0000211,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 3,
            "prevalence": 0.0000211,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000021116351094530865
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344125\\/CTA-Poll-16-Primary-reason-for-using-the-virtual-trial-model",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344119\\/CTA-Poll-13-Timeline-of-using-decentralized-virtual-clinical-trials",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344124\\/CTA-Poll-15-Addressing-clinical-trial-disruptions",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344129\\/CTA-Poll-20-Relevance-of-data-governance-or-privacy",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344118\\/CTA-Poll-12-Usage-of-decentralized-virtual-clinical-trials",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344115\\/CTA-Poll-11-Decentralized-virtual-clinical-trials-due-to-Covid-19",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350244\\/Pharma-Poll-42-Pharma-value-best-supported-by-Remote-Patient-Monitoring",
            "cookies": 0.0000211,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 3,
            "prevalence": 0.0000211,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000021116351094530865
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350246\\/Pharma-Poll-43-Main-benefit-of-integrating-digital-tools-into-trials",
            "cookies": 0.0000211,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 3,
            "prevalence": 0.0000211,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000021116351094530865
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350256\\/Pharma-Poll-46-Most-important-consideration-to-ensure-success-of-virtual-clinical-trials",
            "cookies": 0.0000211,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 3,
            "prevalence": 0.0000211,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000021116351094530865
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344131\\/CTA-Poll-21-Evaluation-of-data-management-solutions",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350253\\/Pharma-Poll-45-Main-design-challenge-of-RPM-technologies",
            "cookies": 0.0000211,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 3,
            "prevalence": 0.0000211,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000021116351094530865
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344123\\/CTA-Poll-14-Impact-of-COVID-19-pandemic-on-clinical-trials",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344128\\/CTA-Poll-19-Mode-of-handling-data-collection",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344127\\/CTA-Poll-18-Risk-of-deviations-of-decentralized-virtual-clinical-trials-vs-traditional-trial-research",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90366637\\/Pharma-Poll-53-Telemedicine-usage-reached-its-peak",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90337837\\/Pharma-Poll-39-In-person-physician-interactions-with-Pharma-Reps",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90366638\\/Pharma-Poll-54-Barriers-preventing-patients-from-using-telemedicine",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350719\\/Pharma-Poll-49-Social-media-barriers-for-pharma-companies",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358478\\/Pharma-Poll-51-Sustainability-efforts",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90366639\\/Pharma-Poll-55-Barriers-preventing-healthcare-providers-from-using-telemedicine",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350697\\/Pharma-Poll-47-Social-media-usage-benefits-for-pharma-companies",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358480\\/Pharma-Poll-52-Challenges-while-achieving-sustainable-manufacturing-practices-copy",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90368762\\/Pharma-Poll-56-Healthcare-industry-trends-accelerated-the-most-by-COVID-19",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350710\\/Pharma-Poll-48-Best-social-media-platforms-for-pharma-companies",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90306878\\/Pharma-Poll-26-Most-important-priorities-over-the-next-12-months",
            "cookies": 0,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90337838\\/Pharma-Poll-40-Best-tool-for-virtual-interactions-among-physicians-and-Pharma-Reps",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350722\\/Pharma-Poll-50-Impact-of-COVID-19-on-social-media-usage",
            "cookies": 0.0000141,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000141,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.00001407756739635391
            },
            "exampleSites": [
                "pharmaceutical-technology.com",
                "www.pharmaceutical-technology.com"
            ]
        }
    ],
    "categories": [],
    "performance": {},
    "cookies": 0.0000141,
    "types": {
        "Document": 63
    },
    "nameservers": [
        "ns-440.awsdns-55.com",
        "ns-898.awsdns-48.net",
        "ns-1127.awsdns-12.org",
        "ns-1912.awsdns-47.co.uk"
    ]
}